Proposed Data Collections Submitted for Public Comment and Recommendations, 67147-67148 [2013-26787]

Download as PDF Federal Register / Vol. 78, No. 217 / Friday, November 8, 2013 / Notices of the Board of Governors. Comments must be received not later than November 26, 2013. A. Federal Reserve Bank of Atlanta (Chapelle Davis, Assistant Vice President) 1000 Peachtree Street NE., Atlanta, Georgia 30309: 1. Ben F. Easterlin, IV, and Tommye B. Easterlin, both of Atlanta, Georgia; to retain voting shares of CBA Bankshares, Inc., and thereby indirectly retain voting shares of Citizens Bank of Americus, both in Americus, Georgia. B. Federal Reserve Bank of Dallas (E. Ann Worthy, Vice President) 2200 North Pearl Street, Dallas, Texas 75201– 2272: 1. George W. Cummings, III; Nanette Weaver Cummings; George W. Cummings, Jr.; Dewey F. Weaver Jr.; Colby Weaver, all of Monroe, Louisiana; Twist Family, LLP; Randall Twist, both of Dallas, Texas; and Dewey Weaver, III, West Monroe, Louisiana; to retain voting shares of Progressive Bancorp, Inc., and thereby indirectly retain voting shares of Progressive Bank, both in Monroe, Louisiana. Board of Governors of the Federal Reserve System, November 5, 2013. Michael J. Lewandowski, Associate Secretary of the Board. [FR Doc. 2013–26819 Filed 11–7–13; 8:45 am] BILLING CODE 6210–01–P TKELLEY on DSK3SPTVN1PROD with NOTICES Notice of Proposals To Engage in or To Acquire Companies Engaged in Permissible Nonbanking Activities The companies listed in this notice have given notice under section 4 of the Bank Holding Company Act (12 U.S.C. 1843) (BHC Act) and Regulation Y, (12 CFR Part 225) to engage de novo, or to acquire or control voting securities or assets of a company, including the companies listed below, that engages either directly or through a subsidiary or other company, in a nonbanking activity that is listed in § 225.28 of Regulation Y (12 CFR 225.28) or that the Board has determined by Order to be closely related to banking and permissible for bank holding companies. Unless otherwise noted, these activities will be conducted throughout the United States. Each notice is available for inspection at the Federal Reserve Bank indicated. The notice also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the question whether the proposal complies with the standards of section 4 of the BHC Act. 18:08 Nov 07, 2013 Board of Governors of the Federal Reserve System, November 5, 2013. Michael J. Lewandowski, Associate Secretary of the Board. [FR Doc. 2013–26818 Filed 11–7–13; 8:45 am] BILLING CODE 6210–01–P FEDERAL RETIREMENT THRIFT INVESTMENT BOARD Senior Executive Service Performance Review Board Federal Retirement Thrift Investment Board. AGENCY: ACTION: Notice. This notice announces the appointment of the members of the Senior Executive Service Performance Review Boards for the Federal Retirement Thrift Investment Board. The purpose of the Performance Review Boards is to view and make recommendations concerning proposed performance appraisals, ratings, and bonuses, and other appropriate personnel actions for members of the Senior Executive Service. SUMMARY: FEDERAL RESERVE SYSTEM VerDate Mar<15>2010 Unless otherwise noted, comments regarding the applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than November 26, 2013. A. Federal Reserve Bank of Dallas (E. Ann Worthy, Vice President) 2200 North Pearl Street, Dallas, Texas 75201– 2272: 1. Central Texas Financial Corp., Cameron, Texas; to engage de novo in lending activities, pursuant to section 225.28(b)(1). Jkt 232001 This notice is effective November 5, 2013. DATES: FOR FURTHER INFORMATION CONTACT: Kelly Powell, HR Specialist, at 202– 942–1681. Title 5, U.S. Code, 4314(c)(4), requires that the appointment of Performance Review Board members be published in the Federal Register before Board service commences. The following persons will serve on the Federal Retirement Thrift Investment Board’s Performance Review Boards which will oversee the evaluation of the performance appraisals of the Senior Executive Service members of the Federal Retirement Thrift Investment Board: Tracey A. Ray, Kimberly Weaver, Mark SUPPLEMENTARY INFORMATION: PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 67147 Walther, Jayant Ahuja, Susan Crowder and Gisile Goethe. James B. Petrick, General Counsel, Federal Retirement Thrift Investment Board. [FR Doc. 2013–26808 Filed 11–7–13; 8:45 am] BILLING CODE 6760–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60–Day–14–0888] Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–7570 or send comments to Kimberly Lane, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an email to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice. Proposed Project Persistence of Viable Influenza Virus in Aerosols (0920–0888, Expiration 05/ 31/2014)—Revision—National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC). Background and Brief Description The National Institute for Occupational Safety and Health (NIOSH) is authorized to conduct research to advance the health and safety of workers under Section 20(a)(1) E:\FR\FM\08NON1.SGM 08NON1 67148 Federal Register / Vol. 78, No. 217 / Friday, November 8, 2013 / Notices of the 1970 Occupational Safety and Health Act. Influenza continues to be a major public health concern because of the substantial health burden from seasonal influenza and the potential for a severe pandemic. Although influenza is known to be transmitted by infectious secretions, these secretions can be transferred from person to person in many different ways, and the relative importance of the different pathways is not known. The likelihood of the transmission of influenza virus by small infectious airborne particles produced during coughing and breathing is particularly unclear. The question of airborne transmission is especially important in healthcare facilities, where influenza patients tend to congregate during influenza season, because it directly impacts the infection control and personal protective measures that should be taken by healthcare workers. The purpose of this study is to measure the amount of viable influenza virus in airborne particles that are produced by patients when they cough, and the size and quantity of the particles carrying the virus. A better understanding of the amount of potentially infectious material released by patients and the size of the particles carrying the virus will assist in determining the possible role of airborne transmission in the spread of influenza and in devising measures to prevent it. 132 to 360. In a previous similar study, the number of potential participants who agree to join the study was 50%, which was lower than anticipated. The increase will allow the study to recruit 180 participants. (3) The number of qualified participants has been increased from 120 to 180. This is necessary to provide a sufficient number of cough aerosol samples with detectable amounts of viable influenza and is based on a previous study, where 10% of aerosol samples had culturable virus. (4) The Informed consent form has been substantially revised to make it easier to read and understand. As a result of the revisions, the burden per response for that form has been reduced from 20 to 15 minutes. (5) Because of the increases in the number of potential and qualified participants, the total burden hours has increased from 51 to 78 hours. (6) The title of the ICR has been changed to ‘‘Factors Influencing the Transmission of Influenza’’ in order to reflect the new focus of the project on influenza viability and to match the title of the human subjects protocol approved by the Institutional Review Board. There are no costs to respondents other than their time. Volunteer adult participants will be recruited by a test coordinator using a poster and flyers describing the study. Interested potential participants will be screened verbally to verify that they have influenza-like symptoms and that they do not have any medical conditions that would preclude their participation. Qualified participants who agree to participate in the study will be asked to read and sign an informed consent form, and then to complete a short health questionnaire. After completing the forms, two nasopharyngeal swabs and one oropharyngeal swab will be collected from the participant. They then will be asked to cough repeatedly into an aerosol particle collection system, and the airborne particles produced by the participant during coughing will be collected and tested. The sounds produced during coughing will also be recorded for analysis and comparison to the amount of virus expelled. The study will require 60 volunteer test subjects each year for 3 years, for a total of 180 test participants. The following revisions have been made to the previous approved information collection request: (1) Initially, potential participants will be screened verbally rather than through the health questionnaire. (2) The number of potential participants has been increased from ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Average burden per response (in hrs.) Number of responses per respondent Total burden (in hrs.) Type of respondents Form name Potential participant .......................... Qualified participant .......................... Qualified participant .......................... Initial verbal screening ..................... Informed consent form ..................... Health questionnaire ........................ 360 180 180 1 1 1 3/60 15/60 5/60 18 45 15 Total ........................................... ........................................................... ........................ ........................ ........................ 78 Kimberly S. Lane, Deputy Director, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [30-Day–14–13AHA] Proposed Project Agency Forms Undergoing Paperwork Reduction Act Review [FR Doc. 2013–26787 Filed 11–7–13; 8:45 am] Centers for Disease Control and Prevention comments to CDC Desk Officer, Office of Management and Budget, Washington, D.C. 20503 or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. World Trade Center Health Program Enrollment & Appeals—Pentagon & Shanksville, Pennsylvania Responders—New—National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC). DEPARTMENT OF HEALTH AND HUMAN SERVICES TKELLEY on DSK3SPTVN1PROD with NOTICES BILLING CODE 4163–18–P The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call (404) 639–7570 or send an email to omb@cdc.gov. Send written VerDate Mar<15>2010 18:08 Nov 07, 2013 Jkt 232001 PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 Background and Brief Description The James Zadroga 9/11 Health and Compensation Act of 2010 (Zadroga Act), promulgated on December 22, E:\FR\FM\08NON1.SGM 08NON1

Agencies

[Federal Register Volume 78, Number 217 (Friday, November 8, 2013)]
[Notices]
[Pages 67147-67148]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-26787]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60-Day-14-0888]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-7570 or 
send comments to Kimberly Lane, 1600 Clifton Road, MS-D74, Atlanta, GA 
30333 or send an email to omb@cdc.gov.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    Persistence of Viable Influenza Virus in Aerosols (0920-0888, 
Expiration 05/31/2014)--Revision--National Institute for Occupational 
Safety and Health (NIOSH), Centers for Disease Control and Prevention 
(CDC).

Background and Brief Description

    The National Institute for Occupational Safety and Health (NIOSH) 
is authorized to conduct research to advance the health and safety of 
workers under Section 20(a)(1)

[[Page 67148]]

of the 1970 Occupational Safety and Health Act. Influenza continues to 
be a major public health concern because of the substantial health 
burden from seasonal influenza and the potential for a severe pandemic. 
Although influenza is known to be transmitted by infectious secretions, 
these secretions can be transferred from person to person in many 
different ways, and the relative importance of the different pathways 
is not known. The likelihood of the transmission of influenza virus by 
small infectious airborne particles produced during coughing and 
breathing is particularly unclear. The question of airborne 
transmission is especially important in healthcare facilities, where 
influenza patients tend to congregate during influenza season, because 
it directly impacts the infection control and personal protective 
measures that should be taken by healthcare workers. The purpose of 
this study is to measure the amount of viable influenza virus in 
airborne particles that are produced by patients when they cough, and 
the size and quantity of the particles carrying the virus. A better 
understanding of the amount of potentially infectious material released 
by patients and the size of the particles carrying the virus will 
assist in determining the possible role of airborne transmission in the 
spread of influenza and in devising measures to prevent it.
    Volunteer adult participants will be recruited by a test 
coordinator using a poster and flyers describing the study. Interested 
potential participants will be screened verbally to verify that they 
have influenza-like symptoms and that they do not have any medical 
conditions that would preclude their participation. Qualified 
participants who agree to participate in the study will be asked to 
read and sign an informed consent form, and then to complete a short 
health questionnaire. After completing the forms, two nasopharyngeal 
swabs and one oropharyngeal swab will be collected from the 
participant. They then will be asked to cough repeatedly into an 
aerosol particle collection system, and the airborne particles produced 
by the participant during coughing will be collected and tested. The 
sounds produced during coughing will also be recorded for analysis and 
comparison to the amount of virus expelled. The study will require 60 
volunteer test subjects each year for 3 years, for a total of 180 test 
participants.
    The following revisions have been made to the previous approved 
information collection request:
    (1) Initially, potential participants will be screened verbally 
rather than through the health questionnaire.
    (2) The number of potential participants has been increased from 
132 to 360. In a previous similar study, the number of potential 
participants who agree to join the study was 50%, which was lower than 
anticipated. The increase will allow the study to recruit 180 
participants.
    (3) The number of qualified participants has been increased from 
120 to 180. This is necessary to provide a sufficient number of cough 
aerosol samples with detectable amounts of viable influenza and is 
based on a previous study, where 10% of aerosol samples had culturable 
virus.
    (4) The Informed consent form has been substantially revised to 
make it easier to read and understand. As a result of the revisions, 
the burden per response for that form has been reduced from 20 to 15 
minutes.
    (5) Because of the increases in the number of potential and 
qualified participants, the total burden hours has increased from 51 to 
78 hours.
    (6) The title of the ICR has been changed to ``Factors Influencing 
the Transmission of Influenza'' in order to reflect the new focus of 
the project on influenza viability and to match the title of the human 
subjects protocol approved by the Institutional Review Board.
    There are no costs to respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondents           Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent       (in hrs.)       (in hrs.)
----------------------------------------------------------------------------------------------------------------
Potential participant.........  Initial verbal               360               1            3/60              18
                                 screening.
Qualified participant.........  Informed consent             180               1           15/60              45
                                 form.
Qualified participant.........  Health                       180               1            5/60              15
                                 questionnaire.
                               ---------------------------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............              78
----------------------------------------------------------------------------------------------------------------


Kimberly S. Lane,
Deputy Director, Office of Scientific Integrity, Office of the 
Associate Director for Science, Office of the Director, Centers for 
Disease Control and Prevention.
[FR Doc. 2013-26787 Filed 11-7-13; 8:45 am]
BILLING CODE 4163-18-P